Here's One 22-Year-Old Who's Fed Up With A&F

Share this content:
I would like to respond to [Abercrombie & Fitch spokesman] Hampton Carney's comments that "the only complaints we get are from people who are older and don't understand what we're doing. This is specifically for 18- to 22-year-olds and no one else."

I am a 22-year-old who works in public relations, meaning I am well-acquainted with the marketing venture of Abercrombie & Fitch. Though advertising clothes alongside sex is not an uncommon marketing tool -- indeed, it seems to be an increasingly popular method of selling --Abercrombie & Fitch's [magalog] and Web site are an overt and tasteless new class of pornographic material, especially considering its identified target market. As a person who is supposed to enjoy your [magalog], I would like to say I am tired of products being sold to me vis-à-vis sex, and I work hard to steer clear of products that choose to rely on it.

Therefore, Mr. Carney, I would like to let you in on something: You have it all backward. The people who dislike what A&F are doing understand exceptionally well how you are choosing to sell your product -- and they disagree with it not because they don't understand, but rather because they do.

Katie M. Stence, Public relations assistant, New York,

Loading links....

Sign up to our newsletters

Company of the Week

SK&A is a leading provider of U.S. healthcare information solutions and databases. As part of IMS Health, SK&A researches and maintains contact and profiling data for over 2 million healthcare providers, including 800,000+ prescribers. SK&A's data supports research and marketing initiatives for life sciences, medical device, managed healthcare, direct marketing, publishing, education and more. SK&A's proprietary databases are telephone-verified twice per year from its world class Research Centers. SK&A enables multi-channel marketing and sets the standard for data quality and reliability. SK&A's customers include many of America's most recognized healthcare, publishing and pharmaceutical institutions.

Featured Listings